C Panella
Overview
Explore the profile of C Panella including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
630
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pascual M, Panella C, Pera M
Colorectal Dis
. 2017 May;
19(6):595-596.
PMID: 28477433
No abstract available.
2.
Sanchez-Velazquez P, Castellvi Q, Villanueva A, Iglesias M, Quesada R, Panella C, et al.
Sci Rep
. 2017 Mar;
7:44821.
PMID: 28327623
Irreversible electroporation (IRE) has recently gained in popularity as an ablative technique, however little is known about its oncological long-term outcomes. To determine the long-time survival of animals treated with...
3.
Sanchez-Velazquez P, Castellvi Q, Villanueva A, Quesada R, Panella C, Caceres M, et al.
Sci Rep
. 2016 Apr;
6:23781.
PMID: 27032535
Irreversible electroporation is a fast-growing liver ablation technique. Although safety has been well documented in small ablations, our aim is to assess its safety and feasibility when a large portion...
4.
Federico A, Cotticelli G, Festi D, Schiumerini R, Addolorato G, Ferrulli A, et al.
Eur Rev Med Pharmacol Sci
. 2015 Jun;
19(10):1922-40.
PMID: 26044241
Alcohol has a direct impact on the digestive system due to its contact with mucosal lining and interference with digestive functions. Various diseases of the gastrointestinal tract, including tumors, may...
5.
Facciorusso A, Nacchiero M, Rosania R, Laonigro G, Giorgio F, Del Prete V, et al.
Minerva Gastroenterol Dietol
. 2012 Mar;
58(1):35-48.
PMID: 22419003
Hepatocarcinogenesis is a process attributed to progressive genomic changes which alter the hepatocellular phenotype producing cellular intermediates evolving into clearly neoplastic cells (hepatocellular carcinoma, HCC). During the preneoplastic phase, the...
6.
Ierardi E, Hassan C, Zullo A, De Francesco V, Della Valle N, Prencipe S, et al.
Dig Liver Dis
. 2009 Jun;
41(11):794-7.
PMID: 19487168
Background And Aim: Segmental colitis associated with diverticula (SCAD) has recently drawn a particular attention in the field of rare forms of colitis because of some peculiarities suggesting both its...
7.
Muscatiello N, Nacchiero M, Della Valle N, Tarollo A, Diterlizzi F, Verderosa G, et al.
Endoscopy
. 2008 Jun;
40(6):540-1.
PMID: 18543143
No abstract available.
8.
Hassan C, Zullo A, De Francesco V, Campo S, Morini S, Panella C, et al.
Endocr Metab Immune Disord Drug Targets
. 2007 Sep;
7(3):187-94.
PMID: 17897045
Conventional treatment of moderate-severe ulcerative colitis (UC) has resulted in only a limited therapeutic benefit. Advancing knowledge of UC pathogenesis and recent advances in biotechnology have led to the development...
9.
Hassan C, Ierardi E, Burattini O, De Francesco V, Zullo A, Stoppino G, et al.
Dig Liver Dis
. 2007 Jul;
39(9):811-7.
PMID: 17652038
Background: Treatment with the anti-tumour necrosis factor alpha monoclonal antibody infliximab has been shown to be effective in moderate-to-severe ulcerative colitis. However, its effect on the mucosal histopathological abnormalities of...
10.
Zullo A, De Francesco V, Scaccianoce G, Manes G, Efrati C, Hassan C, et al.
Dig Liver Dis
. 2007 Jul;
39(9):806-10.
PMID: 17644057
Background: Helicobacter pylori eradication rate following standard triple therapy is decreasing worldwide. A quadruple therapy with lactoferrin and a levofloxacin-based triple therapy has been found to achieve a very high...